Review Q's Week 6 Flashcards
1. patho: vasculitis (1-33) 2. pharma dyslipidemia control (34-59) 3. patho lab: vascular diseases (60-68) 4. biochem: energy utilization (69-100) 5. patho lab: lipid disorders (101-114) 6. clinical medicine: choronic myocardial ischemia (115-152)
T/F: in vasculitis, the ability of the vessel to hold more blood is increased due to the thickening of blood vessels
false, the elastic property of the vessels is lost so it’s blood holding capabilities are hindered
Which of the following occur in small vessels?
a. Giant Cell Arteritis
b. Kawasaki Disease
c. Leukocytoclastic Vasculitis
d. Takayasu Arteritis
c. Leukocytoclastic Vasculitis
60 year-old women comes in complaining of headaches, joint and facial pain, fever, and difficulties with vision. Whats the diagnosis?
Giant cell arteritis
(other symptoms include jaw and tongue claudication- pain when eating or chewing)
What are different names of giant cell arteritis?
Granulomatous arteritis
arteritis cranialis
Horton disease
arteritis of the aged
Mechanism of giant cell arteritis. What findings are used to diagnose (4)?
Autoimmune reaction to elastic fibers in vessel wall
Panartheritis, aka inflammation involving all layers of an artery
Multinucleated giant cells
thick wall due to infiltrates (neutrophils, etc.)
Fragmented IEL (black coil in picture)
In Panartheritis, where does the inflammation start.
The inflammation starts in the media, and then spreads to the intima and adventitia- ending up in all the layers
media ⇨ intima & adventitia
A 30 year-old women comes in with painful, cool, and pale extremities, dizziness, headaches, chest pain, hypertension, and abdominal pain. Her renin levels are high and angiography is shown below. Diagnosis?
takayasu arteritis
(low perfusion to kidneys caused high renin, which increased BP)
What is characteristic of Takayasu arteritis?
Aneurysm (formation in the coronary vessels)
takayasu arteritis is also known as pulseless disease. Why?
When it affects the subclavian branch of the aorta, you won’t be able to feel a pulse due to the thickening of the wall, hence the name
Describe the vessels of takayasu arteritis
thick sclerosing vessels with a narrow lumen
Sclerosing arteritis of media ⇨ adventitia
Target population of
giant cell arteritis VS Takayasu arteritis
giant cell arteritis= older women (50+)
Takayasu arteritis= younger women (50-)
Polyarteritis Nodosa is
a. Granulomas
b. Necrotizing
b. Necrotizing
(giant cell arteritis and Takayasu arteritis are A)
What causes the inflammation in Polyarteritis Nodosa?
its immune (complex) mediated inflammation
polyarteritis nodosa affects which parts of the vessel wall?
Affects the whole vessel wall; transmural necrotizing arteritis
What causes the microaneurisms in polyarteritis nodosa?
Segmental inflammation & necrosis ⇨ macrophages clean the necrosis ⇨ healing occurs (fibrin mesh, platelets, collagen) ⇨ the scar tissue is not as flexible/elastic ⇨ microaneurysmsor ruptures ⇨ nodules
Whats a characteristic of polyarteritis nodosa?
Mural fibrinoid necrosis
A four year olf child comes in with conjunctivits, lymphadenopathy, and a strawberry looking toungue + cracked lips. Diagnosis?
Kawasaki Disease
A biopsy of a 2 year old girl shows bulges on the heart. diagnose and explain.
multiple coronary aneurysms formed the bulges on the heart
kawasaki disease
Necrotizing arteritis with VS without mucocutaneous lymph node (MCLN)
with MCLN= kawasaki disease
without MCLN= Polyarteritis nodosa
Symptoms of Kawasaki disease
(+ how do diagnose?)
What does Wegener granulomatosis affect?
upper/lower respireatory tract
lungs
ear, nose, throat
kidney
Patient comes in with nasal passage inflammation, numbness, weakness, scarrying on the foot, and a history of asthma. After further investigation, eosinophil count is high and the scar tissue contains granulomas. Diagnose.
Churg Strauss Syndrome
(patients often misdiagnosed with allergies)
Antineutrophil Cytoplasmic Antibodies (ANCA) are used to diagnose which types of vasculitis?
Wegener granulomatosis
Churg Strauss Syndrome
Leukocytoclastic Vasculitis
Microscopic polyangiitis
Patient comes in with palpable purpura. Further tests reveal high ANCA levels. diagnose.
Leukocytoclastic Vasculitis
vasculitis + respiratory granuloma + no eosinophils=
wegner granulomaotosis
vasculitis + respiratory granuloma + eosinophils+ asthma=
churg strauss syndrome
vasculitis + no respiratory symptoms + skin purpura
Leukocytoclastic vasculitis
T/F: Buerger Disease (Thromboangiitis Obliterans) only affects arteries and veins
false, its called “angiitis” and not Arteritis because it affects all kinds of blood vessels, arteries, veins, nerves. the pain is due to the nerve inflammation.
Who does Buerger Disease (Thromboangiitis Obliterans) most likely affect? Where?
Heavy smokers + young males
affects hands and legs (blood flow blocked due to inflammation, may be blocked to the point of gangrene and amputation)
T/F: Thromboangiitis Obliterans is reversible at early stages of the disease if the smokers quit
true
T/F: Raynaud’s cannot cause ischemia
false, secondary Raynaud’s or Raynaud’s Phenomenon can because its accompanied by other conditions
Diagnose
Buerger Disease
Why does Raynaud’s Disease occur?
overreaction to cold
When is endogenous cholesterol synthesis highest?
at night
Mechanism of action of Statins.
Inhibitors of Cholesterol Biosynthesis
the rate-limiting enzyme in cholesterol biosynthesis is …
HMG-COA reductase
How do statins cause a decrease in LDL?
they stop cholesterol synthesis and the body compensates by making more LDL receptors so they can utilize the LDL’s of the circulation (higher LDL uptake)
When are statins contraindicated?
(adverse side effects=2)
in pregnancy
What’s the most pronounced effect of fibrates?
decrease in plasma triglyceride
first line treatment of primary hypertriglyceridemia.
Fibrates
T/F: Fibrates affect both LDL and HDL concentrations
true, decrease LDL and increase HDL
Fibrates are agonists of which receptors? What are these receptors?
α peroxisomal-proliferator activator receptors (PPARα), which are nuclear transcription factors that play a role in lipid metabolism
(+ PPARα= + lipid metabolism)
3 side-effects of fibrates
- Cholelithiasis (formation of gallstones),
- weight gain
- alopecia.
Mechanism of action of bile acid-binding resins.
Bile acid binding agents are large polymers of hydrocarbons that can bind bile salts and block intestinal absorbtion. (decrease bils salt reabsorbtion)
This causes the liver to start to convert cholesterol into bile acids to compensate, thus decreasing hepatic cholesterol. (LDL is taken from the circulation by the liver)
bile acid-binding resins mostly affect which of the following?
a. HDL
b. LDL
b. LDL
(May raise HDL levels slightly)
Side effects of Cholestyramine + Colestipol
GI disturbances such as constipation and bloating
Interfere with absorption of some drugs like warfarin and digitalis
Mechanism of action of Ezetimibe
inhibit Cholesterol Absorption in the brush border of enterocytes in the duodenum.
How does Nicotinic Acid reduce plasma levels of VLDL?
by inhibiting the synthesis of fatty acids in the liver
How does Nicotinic Acid reduce plasma TG levels?
By reducing lipolysis in adipose tissue
What’s the most effective agent for increasing HDL?
Nicotinic Acid (Niacin)
2 side effects of Nicotinic Acid (Niacin)
Weight gain due to inhibition of lipolysis
Hyperuricemia precipitates gout.
Mechanism of action of Omega-3-fatty acids
Inhibit VLDL and TG synthesis in the liver.
What is Proprotein Convertase Subtilisin/Kexin type 9 (PCSK9)?
a serine protease involved in cholesterol homeostasis- reducing serum LDL clearance.
(PCSK9 is a serine protease that reduces both hepatic and extrahepatic LDL receptors)
Mechanism of action of Evolocumab
Monoclonal antibodies that inhibit PCSK9 have emerged as a new class of drugs that very effectively lower LDL cholesterol levels (by stopping what inhibits the LDL clearance)
Which of the following most effectively lowers LDL?
a. Evolocumab
b. Simvastatin
c. Clofibrate
d. Nicotinic Acid (Niacin)
e. Lovastatin
f. Ezetimibe
g. Cholestyramine
b. Simvastatin
Which of the following most effectively lowers HDL?
a. Evolocumab
b. Simvastatin
c. Clofibrate
d. Nicotinic Acid (Niacin)
e. Lovastatin
f. Ezetimibe
g. Cholestyramine
d. Nicotinic Acid (Niacin)
Which of the following most effectively lowers triglycerides?
a. Evolocumab
b. Simvastatin
c. Clofibrate
d. Nicotinic Acid (Niacin)
e. Lovastatin
f. Ezetimibe
g. Cholestyramine
c. Clofibrate
Which of the following is used to treat combined hyperlipidemia?
a. Evolocumab
b. Simvastatin
c. Clofibrate
d. Nicotinic Acid (Niacin)
e. Lovastatin
f. Ezetimibe
g. Cholestyramine
d. Nicotinic Acid (Niacin)